You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 29, 2026
Sale
Calculated transaction value
$283.97K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 28, 2026
Public filing date
Sep 29, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$485.54
Sep 28, 2026
First close after public filing
$541.89
Sep 30, 2026
30-day return after filing
+9.53%
Through Oct 29, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 600 shares @ $473.28
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000151
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$5.69M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $132.28K |
| United Therapeutics Corp UTHR Current | Sale | Sep 28, 2026 | $283.97K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $322.63K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $38.02K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $76.27K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $95.49K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $287.91K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $486.43K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $651.54K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $334.1K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $743.65K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $399.68K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $638.37K |
| United Therapeutics Corp UTHR | Sale | Sep 28, 2026 | $77.76K |
| United Therapeutics Corp UTHR | Exercise | Sep 28, 2026 | $0 |